Sarbanes-Oxley Act

In 2010, a lessening of the regulatory burden on biotech startups looks promising.

We have used the biological processes of microorganisms for 6,000 years to make useful food products, such as bread and cheese, and to preserve dairy products.

Letters, Testimony & Comments

July 26 2012
Jeffrey S. Hatfield, President and Chief Executive Officer, Vitae Pharmaceuticals On behalf of the Biotechnology Industry...
June 21 2010
Re: Medicare Coverage Gap Discount Program Model Manufacturer Agreement – [CMS-4151-NC] RIN 0938-AQ04 Dear Administrator Tavenner...
BIO advocated for a provision in financial services reform that would ease regulatory burdens for small public biotechnology companies....
The 2009 Government-Business Forum on Small Business Capital Formation recommended a permanent exemption for small companies from Section...

Press Releases

June 29 2011
WASHINGTON, D.C. (Wednesday, June 29, 2011) - The Biotechnology Industry Organization (BIO) released today a summary...
December 11 2009
WASHINGTON, D.C. (Friday, December 11, 2009) - The Biotechnology Industry Organization (BIO) commends the House of...
February 28 2008
Home Owndership, Manufacturing and Economic Growth (HOME) Act Mends Problems for Biotech WASHINGTON, D.C. (...
December 12 2007
WASHINGTON, D.C. (Wednesday, December 12, 2007) -  At today’s House Small Business Committee hearing on...
July 25 2007
WASHINGTON, D.C. (July 25, 2007) -- Jim Greenwood, president and CEO of the Biotechnology Industry Organization (BIO...